secwatch.observer — SEC 8-K summary
======================================

Issuer:     Outset Medical, Inc. (OM)
CIK:        0001484612
Form:       8-K
Filed at:   2023-05-03T23:59:59+00:00
Accession:  0000950170-23-017186
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Outset Medical Q1 revenue $33.5M (+9.5% YoY); raises FY2023 revenue and margin guidance
--------------------------------------------------------------------------------

- Revenue $33.5M, up 9.5% YoY; product revenue $27.8M (+8.2%), service revenue $5.7M (+16.4%).
- Gross margin 19.2% (20.3% non-GAAP), up from 14.5% a year ago; product margin 25.1% vs 10.0%.
- Net loss ($44.0M) or ($0.90) per share; non-GAAP net loss ($35.4M) or ($0.72) per share.
- FY2023 revenue guidance raised to $144-$150M (prior $140-$150M); gross margin guidance raised to low-20% (from ~20%).
- Added over 30 new hospital sites in Q1, largest quarterly new site growth since 2021; cash $252.5M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1484612/000095017023017186/0000950170-23-017186-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1484612/000095017023017186/om-20230503.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-017186

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer